Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2153

1.

Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis.

Tanaka Y, Shirai T, Asada K, Muramatsu A, Katsumata M, Suda T.

Clin Case Rep. 2019 Mar 2;7(4):731-734. doi: 10.1002/ccr3.2068. eCollection 2019 Apr.

PMID:
30997074
2.

Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.

Watanabe K, Ishii H, Kiyomi F, Terasaki Y, Hebisawa A, Kawabata Y, Johkoh T, Sakai F, Kondoh Y, Inoue Y, Azuma A, Suda T, Ogura T, Inase N, Homma S; Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases in Japan.

Respir Investig. 2019 Apr 10. pii: S2212-5345(18)30258-2. doi: 10.1016/j.resinv.2019.02.007. [Epub ahead of print] Review.

PMID:
30981683
3.

Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature.

Fukada A, Toyoshima M, Nozue T, Suda T.

Intern Med. 2019 Mar 28. doi: 10.2169/internalmedicine.2515-18. [Epub ahead of print]

4.

Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.

Fujisawa T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, Kitamura H, Enomoto N, Egashira R, Sumikawa H, Iwasawa T, Matsushita S, Sugiura H, Hashisako M, Tanaka T, Terasaki Y, Kunugi S, Kitani M, Okuda R, Horiike Y, Enomoto Y, Yasui H, Hozumi H, Suzuki Y, Nakamura Y, Fukuoka J, Johkoh T, Kondoh Y, Ogura T, Inoue Y, Hasegawa Y, Inase N, Homma S, Suda T.

Eur Respir J. 2019 Mar 17. pii: 1802243. doi: 10.1183/13993003.02243-2018. [Epub ahead of print]

PMID:
30880283
5.

TUBB1 dysfunction in inherited thrombocytopenia causes genome instability.

Matsumura T, Nakamura-Ishizu A, Takaoka K, Maki H, Muddineni SSNA, Wang CQ, Suzushima H, Kawakita M, Asou N, Matsuoka M, Kurokawa M, Osato M, Suda T.

Br J Haematol. 2019 Mar 10. doi: 10.1111/bjh.15835. [Epub ahead of print]

PMID:
30854628
6.

Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment.

Ochiai N, Nakachi Y, Yokoo T, Ichihara T, Eriksson T, Yonemoto Y, Kato T, Ogata H, Fujimoto N, Kobayashi Y, Udagawa N, Kaku S, Ueki T, Okazaki Y, Takahashi N, Suda T.

Commun Biol. 2019 Mar 1;2:86. doi: 10.1038/s42003-019-0334-5. eCollection 2019.

7.

GSTP1 as a potential predictive factor for adverse events associated with platinum-based antitumor agent-induced peripheral neuropathy.

Katayanagi S, Katsumata K, Mori Y, Narahara K, Shigoka M, Matsudo T, Enomoto M, Suda T, Ishizaki T, Hisada M, Nagakawa Y, Tsuchida A.

Oncol Lett. 2019 Mar;17(3):2897-2904. doi: 10.3892/ol.2019.9907. Epub 2019 Jan 8.

8.

Dynamic Changes in the Niche with N-Cadherin Revisited: The HSC "Niche Herein".

Nakamura-Ishizu A, Suda T.

Cell Stem Cell. 2019 Mar 7;24(3):355-356. doi: 10.1016/j.stem.2019.02.007.

PMID:
30849365
9.

Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer.

Ozawa Y, Amano Y, Kanata K, Hasegwa H, Matsui T, Kakutani T, Koyauchi T, Tanahashi M, Niwa H, Yokomura K, Suda T.

Med Oncol. 2019 Mar 1;36(4):33. doi: 10.1007/s12032-019-1255-3.

PMID:
30825015
10.

PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem Cells.

Tan DQ, Li Y, Yang C, Li J, Tan SH, Chin DWL, Nakamura-Ishizu A, Yang H, Suda T.

Cell Rep. 2019 Feb 26;26(9):2316-2328.e6. doi: 10.1016/j.celrep.2019.02.001.

11.

Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.

Hozumi H, Hasegawa H, Miyashita K, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T.

Respirology. 2019 Feb 25. doi: 10.1111/resp.13506. [Epub ahead of print]

PMID:
30803100
12.

Chronic pulmonary aspergillosis may cause eosinophilic granulomatosis with polyangiitis via allergic bronchopulmonary aspergillosis.

Harada M, Imokawa S, Miwa S, Nihashi F, Aono Y, Amano Y, Uto T, Sato J, Suda T.

Oxf Med Case Reports. 2019 Feb 16;2019(2):omy126. doi: 10.1093/omcr/omy126. eCollection 2019 Feb.

13.

Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.

Akiyama N, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inami N, Matsuura S, Kaida Y, Uto T, Matsui T, Asada K, Matsuda H, Fujii M, Toyoshima M, Suda T.

Invest New Drugs. 2019 Feb 21. doi: 10.1007/s10637-019-00747-x. [Epub ahead of print]

PMID:
30790149
14.

Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.

Yasui H, Inui N, Karayama M, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T.

Respir Med. 2019 Jan;146:76-80. doi: 10.1016/j.rmed.2018.11.020. Epub 2018 Dec 12.

PMID:
30665522
15.

Submucosal painting for gastroduodenal stent placement.

Morita S, Suda T, Terai S.

Dig Endosc. 2019 Jan 21. doi: 10.1111/den.13349. [Epub ahead of print] No abstract available.

PMID:
30664261
16.

Sphingosine-1-phosphate signaling modulates terminal erythroid differentiation through the regulation of mitophagy.

Yang C, Hashimoto M, Lin QXX, Tan DQ, Suda T.

Exp Hematol. 2019 Apr;72:47-59.e1. doi: 10.1016/j.exphem.2019.01.004. Epub 2019 Jan 16.

17.

Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.

Hozumi H, Fujisawa T, Nakashima R, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Inui N, Nakamura Y, Mimori T, Suda T.

J Rheumatol. 2019 Jan 15. pii: jrheum.180778. doi: 10.3899/jrheum.180778. [Epub ahead of print]

PMID:
30647164
18.

A cut-off value of shear wave speed to distinguish nonalcoholic steatohepatitis candidates.

Suda T, Kanefuji T, Abe A, Nagayama I, Hoshi T, Morita S, Yagi K, Hatakeyama S, Hayatsu M, Hasegawa N, Terai S.

Medicine (Baltimore). 2019 Jan;98(2):e13958. doi: 10.1097/MD.0000000000013958.

19.

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype.

Olson AL, Gifford AH, Inase N, Fernández Pérez ER, Suda T.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180077. doi: 10.1183/16000617.0077-2018. Print 2018 Dec 31. Review.

20.

Acute liver failure due to severe Herpes simplex viral hepatitis in an elderly woman: A case of initial infection.

Suda T, Hodo Y, Shirota Y, Ogawa H, Sato K, Wakabayashi T.

Hepatol Res. 2018 Dec 21. doi: 10.1111/hepr.13301. [Epub ahead of print]

PMID:
30575229
21.

Modification of the bone marrow MSC population in a xenograft model of early multiple myeloma.

Berlier JL, Rethnam M, Banu Binte Abdul Majeed A, Suda T.

Biochem Biophys Res Commun. 2019 Jan 22;508(4):1175-1181. doi: 10.1016/j.bbrc.2018.11.178. Epub 2018 Dec 13.

PMID:
30553454
22.

Gastroduodenal intussusception of a gastric carcinoma.

Suda T, Hodo Y, Shirota Y.

Dig Endosc. 2019 Mar;31(2):e38-e39. doi: 10.1111/den.13313. Epub 2019 Jan 24. No abstract available.

PMID:
30536924
23.

Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.

Tsuchiya K, Suzuki Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Baba S, Suda T.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):1031-1033. doi: 10.1164/rccm.201806-1115IM. No abstract available.

PMID:
30525877
24.

Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29.

PMID:
30498034
25.

Thrombopoietin Metabolically Primes Hematopoietic Stem Cells to Megakaryocyte-Lineage Differentiation.

Nakamura-Ishizu A, Matsumura T, Stumpf PS, Umemoto T, Takizawa H, Takihara Y, O'Neil A, Majeed ABBA, MacArthur BD, Suda T.

Cell Rep. 2018 Nov 13;25(7):1772-1785.e6. doi: 10.1016/j.celrep.2018.10.059.

26.

Green epithelium revealed by narrow-band imaging (NBI): a feature for practical assessment of extent of gastric cancer after H. pylori eradication.

Yagi K, Nagayama I, Hoshi T, Abe S, Morita SI, Suda T, Hasegawa G, Sato YI, Terai S.

Endosc Int Open. 2018 Nov;6(11):E1289-E1295. doi: 10.1055/a-0746-3449. Epub 2018 Nov 7.

27.

Immobilization of DNA with nitrogen mustard-biotin conjugate for global epigenetic analysis.

Kojima N, Suda T, Kurinomaru T, Kurita R.

Anal Chim Acta. 2018 Dec 28;1043:107-114. doi: 10.1016/j.aca.2018.09.008. Epub 2018 Sep 8.

PMID:
30392657
28.

Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.

Enomoto N, Oyama Y, Enomoto Y, Yasui H, Karayama M, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318809476. doi: 10.1177/1479972318809476. Epub 2018 Oct 31.

29.

Direct pulmonary infiltrates as an initial manifestation of chronic lymphocytic leukemia.

Fukada A, Yasui H, Uto T, Suzuki S, Sato J, Imokawa S, Suda T.

Respir Med Case Rep. 2018 Oct 15;25:282-285. doi: 10.1016/j.rmcr.2018.10.011. eCollection 2018.

30.

[Robot Assisted Thoracic Surgery Procedure].

Tochii S, Suda T.

Kyobu Geka. 2018 Sep;71(10):833-837. Japanese.

PMID:
30310035
31.

The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.

Ng KP, Manjeri A, Lee LM, Chan ZE, Tan CY, Tan QD, Majeed A, Lee KL, Chuah C, Suda T, Ong ST.

PLoS One. 2018 Oct 11;13(10):e0205254. doi: 10.1371/journal.pone.0205254. eCollection 2018.

32.

IgG4-related disease presenting with combined pulmonary fibrosis and emphysema (CPFE).

Kono M, Nakamura Y, Oyama Y, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Enomoto Y, Kobayashi T, Miki Y, Hashimoto D, Enomoto N, Colby TV, Suda T, Nakamura H.

Respir Med Case Rep. 2018 Oct 3;25:257-260. doi: 10.1016/j.rmcr.2018.09.017. eCollection 2018.

33.

Estrous detection by continuous measurements of vaginal temperature and conductivity with supervised machine learning in cattle.

Higaki S, Miura R, Suda T, Andersson LM, Okada H, Zhang Y, Itoh T, Miwakeichi F, Yoshioka K.

Theriogenology. 2019 Jan 1;123:90-99. doi: 10.1016/j.theriogenology.2018.09.038. Epub 2018 Sep 27.

PMID:
30292860
34.

Clinical characteristics and risk factors for stent-stone complex formation following biliary plastic stent placement in patients with common bile duct stones.

Kaneko J, Kawata K, Watanabe S, Chida T, Matsushita M, Suda T, Kobayashi Y.

J Hepatobiliary Pancreat Sci. 2018 Oct;25(10):448-454. doi: 10.1002/jhbp.584. Epub 2018 Oct 22.

PMID:
30289200
35.

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C.

Suda T, Tatsumi T, Nishio A, Kegasawa T, Yoshioka T, Yamada R, Furuta K, Kodama T, Shigekawa M, Hikita H, Sakamori R, Fukuhara T, Matsuura Y, Takehara T.

Hepatol Commun. 2018 Sep 25;2(10):1247-1258. doi: 10.1002/hep4.1240. eCollection 2018 Oct.

36.

Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms.

Ozawa Y, Koda K, Akahori D, Matsui T, Hasegawa H, Kakutani T, Amano T, Tanahashi M, Niwa H, Kunimoto Y, Yamada K, Yokomura K, Suda T.

Anticancer Res. 2018 Oct;38(10):5937-5941. doi: 10.21873/anticanres.12939.

PMID:
30275222
37.

Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.

Suzuki Y, Yoshimura K, Enomoto Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.

Sci Rep. 2018 Sep 19;8(1):14074. doi: 10.1038/s41598-018-32478-z.

38.

IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium.

Niwa M, Fujisawa T, Mori K, Yamanaka K, Yasui H, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suzuki T, Maekawa M, Suda T.

J Immunol. 2018 Oct 15;201(8):2392-2402. doi: 10.4049/jimmunol.1800147. Epub 2018 Sep 17.

PMID:
30224514
39.

Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis.

Karayama M, Inui N, Tanaka K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Suda T.

Med Oncol. 2018 Sep 5;35(11):139. doi: 10.1007/s12032-018-1199-z.

PMID:
30187148
40.

Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis.

Suzuki Y, Shirai M, Asada K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shirai T, Hayakawa H, Suda T.

Sci Rep. 2018 Sep 3;8(1):13129. doi: 10.1038/s41598-018-31565-5.

41.

Successful treatment of aortic dissection during sorafenib therapy for hepatocellular carcinoma.

Tsuchiya A, Ogawa M, Watanabe Y, Kimura N, Hayashi K, Suda T, Terai S.

Clin Case Rep. 2018 Jul 1;6(8):1643-1644. doi: 10.1002/ccr3.1674. eCollection 2018 Aug.

42.

The Value of 18F-FDG PET in the Diagnosis of Intertrabecular Vertebral Metastasis in a Small Cell Lung Cancer Patient with a High Serum CEA Level.

Morita S, Suda T, Oda C, Kobayashi M, Hoshi T, Kanefuji T, Yagi K, Hasegawa G, Terai S.

Intern Med. 2019 Feb 1;58(3):415-418. doi: 10.2169/internalmedicine.1394-18. Epub 2018 Aug 24.

43.

Differences in airway structural changes assessed by 3-dimensional computed tomography in asthma and asthma-chronic obstructive pulmonary disease overlap.

Niwa M, Fujisawa T, Karayama M, Furuhashi K, Mori K, Hashimoto D, Yasui H, Suzuki Y, Hozumi H, Enomoto N, Nakamura Y, Inui N, Suda T.

Ann Allergy Asthma Immunol. 2018 Dec;121(6):704-710.e1. doi: 10.1016/j.anai.2018.08.006. Epub 2018 Aug 21.

PMID:
30138669
44.

Successful EUS-guided retrograde pancreatic duct stent placement for refractory pancreaticojejunostomy stricture after pancreaticoduodenectomy with a forward-viewing echoendoscope.

Hodo Y, Shirota Y, Suda T, Wakabayashi T.

VideoGIE. 2018 Apr 24;3(6):196-198. doi: 10.1016/j.vgie.2018.03.009. eCollection 2018 Jun. No abstract available.

45.

An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases.

Tsuchiya K, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.

Intern Med. 2018 Dec 1;57(23):3423-3427. doi: 10.2169/internalmedicine.1062-18. Epub 2018 Aug 10.

46.

Agent-Based Modeling and Simulation of Nosocomial Infection among Healthcare Workers during Ebola Virus Disease Outbreak in Sierra Leone.

Jones-Konneh TEC, Suda T, Sasaki H, Egawa S.

Tohoku J Exp Med. 2018 Aug;245(4):231-238. doi: 10.1620/tjem.245.231.

47.

Generation of 1,25-dihydroxyvitamin D3 in Cyp27b1 knockout mice by treatment with 25-hydroxyvitamin D3 rescued their rachitic phenotypes.

Nishikawa M, Yasuda K, Takamatsu M, Abe K, Nakagawa K, Tsugawa N, Hirota Y, Tanaka K, Yamashita S, Ikushiro S, Suda T, Okano T, Sakaki T.

J Steroid Biochem Mol Biol. 2019 Jan;185:71-79. doi: 10.1016/j.jsbmb.2018.07.012. Epub 2018 Jul 18.

PMID:
30031146
48.

LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.

Enomoto Y, Matsushima S, Shibata K, Aoshima Y, Yagi H, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T.

Clin Sci (Lond). 2018 Jul 31;132(14):1565-1580. doi: 10.1042/CS20180435. Print 2018 Jul 31.

49.

Molecular Communication: A Personal Perspective.

Suda T, Nakano T.

IEEE Trans Nanobioscience. 2018 Oct;17(4):424-432. doi: 10.1109/TNB.2018.2851951. Epub 2018 Jul 2.

PMID:
29994715
50.

Japanese guideline for the treatment of idiopathic pulmonary fibrosis.

Homma S, Bando M, Azuma A, Sakamoto S, Sugino K, Ishii Y, Izumi S, Inase N, Inoue Y, Ebina M, Ogura T, Kishi K, Kishaba T, Kido T, Gemma A, Goto Y, Sasaki S, Johkoh T, Suda T, Takahashi K, Takahashi H, Taguchi Y, Date H, Taniguchi H, Nakayama T, Nishioka Y, Hasegawa Y, Hattori N, Fukuoka J, Miyamoto A, Mukae H, Yokoyama A, Yoshino I, Watanabe K; Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society.

Respir Investig. 2018 Jul;56(4):268-291. doi: 10.1016/j.resinv.2018.03.003. Epub 2018 Jul 3. Review.

PMID:
29980444

Supplemental Content

Support Center